{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:22:18Z","timestamp":1782537738256,"version":"3.54.5"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Earlier diagnosis and treatment of Alzheimer\u2019s disease would greatly benefit from the identification of biomarkers at the prodromal stage. Using a prominent animal model of aspects of the disease, we here show using clinically relevant methodologies that very young, pre-pathological PDAPP mice, which overexpress mutant human amyloid precursor protein in the brain, exhibit two cryptic deficits that are normally undetected using standard methods of assessment. Despite learning a spatial memory task normally and displaying normal brain glucose uptake, they display faster forgetting after a long delay following performance to a criterion, together with a strong impairment of brain glucose uptake at the time of attempted memory retrieval. Preliminary observations suggest that these deficits, likely caused by an impairment in systems consolidation, could be rescued by immunotherapy with an anti-\u03b2-amyloid antibody. Our data suggest a biomarker strategy for the early detection of \u03b2-amyloid-related abnormalities.<\/jats:p>","DOI":"10.1038\/ncomms11761","type":"journal-article","created":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T23:51:49Z","timestamp":1464825109000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Early detection of cryptic memory and glucose uptake deficits in pre-pathological APP mice"],"prefix":"10.1038","volume":"7","author":[{"given":"V.","family":"Beglopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Tulloch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.","family":"Roe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Daumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Ferrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. T.","family":"Hyman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. A. T.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. G. M.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,1]]},"reference":[{"key":"BFncomms11761_CR1","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/WNL.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann, G. et al. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology 34, 939\u2013944 (1984).","journal-title":"Neurology"},{"key":"BFncomms11761_CR2","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1093\/brain\/121.9.1631","volume":"121 (Pt 9)","author":"NC Fox","year":"1998","unstructured":"Fox, N. C., Warrington, E. K., Seiffer, A. L., Agnew, S. K. & Rossor, M. N. Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer\u2019s disease. A longitudinal prospective study. Brain 121 (Pt 9), 1631\u20131639 (1998).","journal-title":"Brain"},{"key":"BFncomms11761_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman, R. J. et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N. Engl. J. Med. 367, 795\u2013804 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms11761_CR4","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1016\/j.jalz.2012.05.2116","volume":"8","author":"H Hampel","year":"2012","unstructured":"Hampel, H., Lista, S. & Khachaturian, Z. S. Development of biomarkers to chart all Alzheimer\u2019s disease stages: the royal road to cutting the therapeutic Gordian Knot. Alzheimers Dement. 8, 312\u2013336 (2012).","journal-title":"Alzheimers Dement."},{"key":"BFncomms11761_CR5","doi-asserted-by":"publisher","first-page":"1488","DOI":"10.1126\/science.1228541","volume":"337","author":"DJ Selkoe","year":"2012","unstructured":"Selkoe, D. J. Preventing Alzheimer\u2019s disease. Science 337, 1488\u20131492 (2012).","journal-title":"Science"},{"key":"BFncomms11761_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/503031a","volume":"503","author":"KS Kosik","year":"2013","unstructured":"Kosik, K. S. Diseases: study neuron networks to tackle Alzheimer\u2019s. Nature 503, 31\u201332 (2013).","journal-title":"Nature"},{"key":"BFncomms11761_CR7","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/j.neuron.2013.12.003","volume":"80","author":"CR Jack Jr.","year":"2013","unstructured":"Jack, C. R. Jr. & Holtzman, D. M. Biomarker modeling of Alzheimer\u2019s disease. Neuron 80, 1347\u20131358 (2013).","journal-title":"Neuron"},{"key":"BFncomms11761_CR8","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/nm.3466","volume":"20","author":"M Mapstone","year":"2014","unstructured":"Mapstone, M. et al. Plasma phospholipids identify antecedent memory impairment in older adults. Nature Med. 20, 415\u2013418 (2014).","journal-title":"Nature Med."},{"key":"BFncomms11761_CR9","doi-asserted-by":"publisher","first-page":"(Suppl 3) 321","DOI":"10.3233\/JAD-2011-0059","volume":"26","author":"EM Reiman","year":"2011","unstructured":"Reiman, E. M. et al. Alzheimer\u2019s Prevention Initiative: a plan to accelerate the evaluation of presymptomatic treatments. J. Alzheimers Dis. 26, (Suppl 3) 321\u2013329 (2011).","journal-title":"J. Alzheimers Dis."},{"key":"BFncomms11761_CR10","unstructured":"DianTrial. http:\/\/www.dian-info.org."},{"key":"BFncomms11761_CR11","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","volume":"71","author":"MC Donohue","year":"2014","unstructured":"Donohue, M. C. et al. The preclinical Alzheimer cognitive composite: measuring amyloid-related decline. JAMA Neurol. 71, 961\u2013970 (2014).","journal-title":"JAMA Neurol."},{"key":"BFncomms11761_CR12","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/373523a0","volume":"373","author":"D Games","year":"1995","unstructured":"Games, D. et al. Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein. Nature 373, 523\u2013527 (1995).","journal-title":"Nature"},{"key":"BFncomms11761_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1126\/science.274.5284.99","volume":"274","author":"K Hsiao","year":"1996","unstructured":"Hsiao, K. et al. Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99\u2013102 (1996).","journal-title":"Science"},{"key":"BFncomms11761_CR14","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/383710a0","volume":"383","author":"K Duff","year":"1996","unstructured":"Duff, K. et al. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1. Nature 383, 710\u2013713 (1996).","journal-title":"Nature"},{"key":"BFncomms11761_CR15","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke, L. et al. High-level neuronal expression of abeta 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050\u20134058 (2000).","journal-title":"J. Neurosci."},{"key":"BFncomms11761_CR16","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular Abeta and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"BFncomms11761_CR17","doi-asserted-by":"publisher","first-page":"3228","DOI":"10.1073\/pnas.96.6.3228","volume":"96","author":"AY Hsia","year":"1999","unstructured":"Hsia, A. Y. et al. Plaque-independent disruption of neural circuits in Alzheimer\u2019s disease mouse models. Proc. Natl Acad. Sci. USA 96, 3228\u20133233 (1999).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11761_CR18","doi-asserted-by":"publisher","first-page":"6483","DOI":"10.1074\/jbc.274.10.6483","volume":"274","author":"D Moechars","year":"1999","unstructured":"Moechars, D. et al. Early phenotypic changes in transgenic mice that overexpress different mutants of amyloid precursor protein in brain. J. Biol. Chem. 274, 6483\u20136492 (1999).","journal-title":"J. Biol. Chem."},{"key":"BFncomms11761_CR19","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/nn.2583","volume":"13","author":"JJ Palop","year":"2010","unstructured":"Palop, J. J. & Mucke, L. Amyloid-beta-induced neuronal dysfunction in Alzheimer\u2019s disease: from synapses toward neural networks. Nat. Neurosci. 13, 812\u2013818 (2010).","journal-title":"Nat. Neurosci."},{"key":"BFncomms11761_CR20","doi-asserted-by":"publisher","first-page":"a006338","DOI":"10.1101\/cshperspect.a006338","volume":"2","author":"L Mucke","year":"2012","unstructured":"Mucke, L. & Selkoe, D. J. Neurotoxicity of amyloid beta-protein: synaptic and network dysfunction. Cold Spring Harb. Perspect. Med. 2, a006338 (2012).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"BFncomms11761_CR21","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1159\/000289226","volume":"7","author":"J Laczo","year":"2010","unstructured":"Laczo, J. et al. Human analogue of the morris water maze for testing subjects at risk of Alzheimer\u2019s disease. Neurodegener. Dis. 7, 148\u2013152 (2010).","journal-title":"Neurodegener. Dis."},{"key":"BFncomms11761_CR22","unstructured":"O\u2019Keefe, J. & Nadel, L. The Hippocampus as a Cognitive Map Clarendon Press (1978)."},{"key":"BFncomms11761_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1146\/annurev.neuro.31.061307.090723","volume":"31","author":"EI Moser","year":"2008","unstructured":"Moser, E. I., Kropff, E. & Moser, M. B. Place cells, grid cells, and the brain\u2019s spatial representation system. Annu. Rev. Neurosci. 31, 69\u201389 (2008).","journal-title":"Annu. Rev. Neurosci."},{"key":"BFncomms11761_CR24","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/319774a0","volume":"319","author":"RG Morris","year":"1986","unstructured":"Morris, R. G., Anderson, E., Lynch, G. S. & Baudry, M. Selective impairment of learning and blockade of long-term potentiation by an N-methyl-D-aspartate receptor antagonist, AP5. Nature 319, 774\u2013776 (1986).","journal-title":"Nature"},{"key":"BFncomms11761_CR25","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/23270","volume":"400","author":"B Bontempi","year":"1999","unstructured":"Bontempi, B., Laurent-Demir, C., Destrade, C. & Jaffard, R. Time-dependent reorganization of brain circuitry underlying long-term memory storage. Nature 400, 671\u2013675 (1999).","journal-title":"Nature"},{"key":"BFncomms11761_CR26","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrn1607","volume":"6","author":"PW Frankland","year":"2005","unstructured":"Frankland, P. W. & Bontempi, B. The organization of recent and remote memories. Nat. Rev. Neurosci. 6, 119\u2013130 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"BFncomms11761_CR27","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/ana.410270502","volume":"27","author":"ST DeKosky","year":"1990","unstructured":"DeKosky, S. T. & Scheff, S. W. Synapse loss in frontal cortex biopsies in Alzheimer\u2019s disease: correlation with cognitive severity. Ann. Neurol. 27, 457\u2013464 (1990).","journal-title":"Ann. Neurol."},{"key":"BFncomms11761_CR28","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease is a synaptic failure. Science 298, 789\u2013791 (2002).","journal-title":"Science"},{"key":"BFncomms11761_CR29","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/297681a0","volume":"297","author":"RGM Morris","year":"1982","unstructured":"Morris, R. G. M., Garrud, P., Rawlins, J. N. & O\u2019Keefe, J. Place navigation impaired in rats with hippocampal lesions. Nature 297, 681\u2013683 (1982).","journal-title":"Nature"},{"key":"BFncomms11761_CR30","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/275317a0","volume":"275","author":"FA Huppert","year":"1978","unstructured":"Huppert, F. A. & Piercy, M. Dissociation between learning and remembering in organic amnesia. Nature 275, 317\u2013318 (1978).","journal-title":"Nature"},{"key":"BFncomms11761_CR31","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1093\/brain\/awf229","volume":"125","author":"MD Kopelman","year":"2002","unstructured":"Kopelman, M. D. Disorders of memory. Brain 125, 2152\u20132190 (2002).","journal-title":"Brain"},{"key":"BFncomms11761_CR32","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1101\/lm.990208","volume":"15","author":"S Daumas","year":"2008","unstructured":"Daumas, S. et al. Faster forgetting contributes to impaired spatial memory in the PDAPP mouse: deficit in memory retrieval associated with increased sensitivity to interference? Learn. Mem. 15, 625\u2013632 (2008).","journal-title":"Learn. Mem."},{"key":"BFncomms11761_CR33","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1037\/h0056308","volume":"60","author":"KJ Hayes","year":"1953","unstructured":"Hayes, K. J. The backward curve: a method for the study of learning. Psychol. Rev. 60, 269\u2013275 (1953).","journal-title":"Psychol. Rev."},{"key":"BFncomms11761_CR34","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1111\/j.1471-4159.1977.tb10649.x","volume":"28","author":"L Sokoloff","year":"1977","unstructured":"Sokoloff, L. et al. The [14C]deoxyglucose method for the measurement of local cerebral glucose utilization: theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897\u2013916 (1977).","journal-title":"J. Neurochem."},{"key":"BFncomms11761_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0304-3940(99)00847-2","volume":"277","author":"JC Dodart","year":"1999","unstructured":"Dodart, J. C., Mathis, C., Bales, K. R., Paul, S. M. & Ungerer, A. Early regional cerebral glucose hypometabolism in transgenic mice overexpressing the V717F beta-amyloid precursor protein. Neurosci. Lett. 277, 49\u201352 (1999).","journal-title":"Neurosci. Lett."},{"key":"BFncomms11761_CR36","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1101\/lm.1.3.203","volume":"1","author":"RI Spooner","year":"1994","unstructured":"Spooner, R. I., Thomson, A., Hall, J., Morris, R. G. M. & Salter, S. H. The Atlantis platform: a new design and further developments of Buresova\u2019s on-demand platform for the water maze. Learn. Mem. 1, 203\u2013211 (1994).","journal-title":"Learn. Mem."},{"key":"BFncomms11761_CR37","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1037\/0033-295X.99.2.195","volume":"99","author":"LR Squire","year":"1992","unstructured":"Squire, L. R. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol. Rev. 99, 195\u2013231 (1992).","journal-title":"Psychol. Rev."},{"key":"BFncomms11761_CR38","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/78682","volume":"6","author":"F Bard","year":"2000","unstructured":"Bard, F. et al. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916\u2013919 (2000).","journal-title":"Nat. Med."},{"key":"BFncomms11761_CR39","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/22124","volume":"400","author":"D Schenk","year":"1999","unstructured":"Schenk, D. et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173\u2013177 (1999).","journal-title":"Nature"},{"key":"BFncomms11761_CR40","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1750-1326-8-15","volume":"8","author":"J Kim","year":"2013","unstructured":"Kim, J. et al. Normal cognition in transgenic BRI2-Abeta mice. Mol. Neurodegener. 8, 15 (2013).","journal-title":"Mol. Neurodegener."},{"key":"BFncomms11761_CR41","doi-asserted-by":"publisher","first-page":"3765","DOI":"10.1523\/JNEUROSCI.4251-12.2013","volume":"33","author":"T Melnikova","year":"2013","unstructured":"Melnikova, T. et al. Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimer-amyloidosis. J. Neurosci. 33, 3765\u20133779 (2013).","journal-title":"J. Neurosci."},{"key":"BFncomms11761_CR42","doi-asserted-by":"publisher","first-page":"3826","DOI":"10.1523\/JNEUROSCI.5171-13.2014","volume":"34","author":"HA Born","year":"2014","unstructured":"Born, H. A. et al. Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J. Neurosci. 34, 3826\u20133840 (2014).","journal-title":"J. Neurosci."},{"key":"BFncomms11761_CR43","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/35050110","volume":"408","author":"C Janus","year":"2000","unstructured":"Janus, C. et al. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979\u2013982 (2000).","journal-title":"Nature"},{"key":"BFncomms11761_CR44","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1038\/35050116","volume":"408","author":"D Morgan","year":"2000","unstructured":"Morgan, D. et al. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982\u2013985 (2000).","journal-title":"Nature"},{"key":"BFncomms11761_CR45","doi-asserted-by":"publisher","first-page":"3417","DOI":"10.1074\/jbc.M109.045187","volume":"285","author":"GS Basi","year":"2010","unstructured":"Basi, G. S. et al. Structural correlates of antibodies associated with acute reversal of amyloid beta-related behavioral deficits in a mouse model of Alzheimer disease. J. Biol. Chem. 285, 3417\u20133427 (2010).","journal-title":"J. Biol. Chem."},{"key":"BFncomms11761_CR46","doi-asserted-by":"publisher","first-page":"11393","DOI":"10.1523\/JNEUROSCI.2021-09.2009","volume":"29","author":"K Yamada","year":"2009","unstructured":"Yamada, K. et al. Abeta immunotherapy: intracerebral sequestration of Abeta by an anti-Abeta monoclonal antibody 266 with high affinity to soluble Abeta. J. Neurosci. 29, 11393\u201311398 (2009).","journal-title":"J. Neurosci."},{"key":"BFncomms11761_CR47","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1016\/j.neuron.2014.05.004","volume":"82","author":"TL Spires-Jones","year":"2014","unstructured":"Spires-Jones, T. L. & Hyman, B. T. The intersection of amyloid beta and tau at synapses in Alzheimer's disease. Neuron 82, 756\u2013771 (2014).","journal-title":"Neuron"},{"key":"BFncomms11761_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/187152709787601830","volume":"8","author":"TE Golde","year":"2009","unstructured":"Golde, T. E., Das, P. & Levites, Y. Quantitative and mechanistic studies of Abeta immunotherapy. CNS Neurol. Disord. Drug Targets 8, 31\u201349 (2009).","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"BFncomms11761_CR49","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1038\/nature17172","volume":"531","author":"DS Roy","year":"2016","unstructured":"Roy, D. S. et al. Memory retrieval by activating engram cells in mouse models of early Alzheimer's disease. Nature 531, 508\u2013512 (2016).","journal-title":"Nature"},{"key":"BFncomms11761_CR50","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1038\/13202","volume":"2","author":"G Riedel","year":"1999","unstructured":"Riedel, G. et al. Reversible neural inactivation reveals hippocampal participation in several memory processes. Nat. Neurosci. 2, 898\u2013905 (1999).","journal-title":"Nat. Neurosci."},{"key":"BFncomms11761_CR51","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1111\/j.1471-4159.2004.02185.x","volume":"88","author":"CA Dickey","year":"2004","unstructured":"Dickey, C. A. et al. Amyloid suppresses induction of genes critical for memory consolidation in APP+PS1 transgenic mice. J. Neurochem. 88, 434\u2013442 (2004).","journal-title":"J. Neurochem."},{"key":"BFncomms11761_CR52","doi-asserted-by":"publisher","first-page":"2654","DOI":"10.1523\/JNEUROSCI.3710-06.2007","volume":"27","author":"G Chen","year":"2007","unstructured":"Chen, G. et al. Active Abeta immunization restores spatial learning in PDAPP mice displaying very low levels of beta-amyloid. J. Neurosci. 27, 2654\u20132662 (2007).","journal-title":"J. Neurosci."},{"key":"BFncomms11761_CR53","doi-asserted-by":"publisher","first-page":"10369","DOI":"10.1523\/JNEUROSCI.5721-09.2010","volume":"30","author":"H Hillen","year":"2010","unstructured":"Hillen, H. et al. Generation and therapeutic efficacy of highly oligomer-specific beta-amyloid antibodies. J. Neurosci. 30, 10369\u201310379 (2010).","journal-title":"J. Neurosci."},{"key":"BFncomms11761_CR54","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1126\/science.1194653","volume":"330","author":"KA Vossel","year":"2010","unstructured":"Vossel, K. A. et al. Tau reduction prevents Abeta-induced defects in axonal transport. Science 330, 198 (2010).","journal-title":"Science"},{"key":"BFncomms11761_CR55","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1172\/JCI78464","volume":"126","author":"KL Possin","year":"2016","unstructured":"Possin, K. L. et al. Cross-species translation of the Morris maze for Alzheimer\u2019s disease. J. Clin. Invest. 126, 779\u2013783 (2016).","journal-title":"J. Clin. Invest."},{"key":"BFncomms11761_CR56","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.neurobiolaging.2011.09.007","volume":"32","author":"EM Reiman","year":"2011","unstructured":"Reiman, E. M. Alzheimer's Disease Biomarkers Working Group for the Alliance for Aging Research. Fluorodeoxyglucose positron emission tomography: emerging roles in the evaluation of putative Alzheimer\u2019s disease-modifying treatments. Neurobiol. Aging 32, 44\u201347 (2011).","journal-title":"Neurobiol. Aging"},{"key":"BFncomms11761_CR57","doi-asserted-by":"publisher","first-page":"4637","DOI":"10.1073\/pnas.0308627101","volume":"101","author":"MD Greicius","year":"2004","unstructured":"Greicius, M. D., Srivastava, G., Reiss, A. L. & Menon, V. Default-mode network activity distinguishes Alzheimer\u2019s disease from healthy aging: evidence from functional MRI. Proc. Natl Acad. Sci. USA 101, 4637\u20134642 (2004).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFncomms11761_CR58","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1126\/science.aac8128","volume":"350","author":"L Kunz","year":"2015","unstructured":"Kunz, L. et al. Reduced grid-cell-like representations in adults at genetic risk for Alzheimer\u2019s disease. Science 350, 430\u2013433 (2015).","journal-title":"Science"},{"key":"BFncomms11761_CR59","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrneurol.2012.202","volume":"8","author":"H Hampel","year":"2012","unstructured":"Hampel, H. & Lista, S. Alzheimer disease: from inherited to sporadic AD-crossing the biomarker bridge. Nat. Rev. Neurol. 8, 598\u2013600 (2012).","journal-title":"Nat. Rev. Neurol."},{"key":"BFncomms11761_CR60","unstructured":"Sperling, R. A. Results from two phase 3 trials of bapineuzumab in mild to moderate Alzheimers disease patients. Am. Neurol. Assoc. https:\/\/cms.psav.com\/library\/ana (2012)."},{"key":"BFncomms11761_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/alzrt269","volume":"6","author":"JL Cummings","year":"2014","unstructured":"Cummings, J. L., Morstoff, T. & Zhong, K. Alzheimer\u2019s disease drug-development pipeline: few candidates, frequent failures. Alzheimer\u2019s Res. Ther. 6, 37\u201342 (2014).","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"BFncomms11761_CR62","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1056\/NEJMe1313943","volume":"370","author":"E Karran","year":"2014","unstructured":"Karran, E. & Hardy, J. Antiamyloid therapy for Alzheimer\u2019s disease--are we on the right road? N. Engl. J. Med. 370, 377\u2013378 (2014).","journal-title":"N. Engl. J. Med."},{"key":"BFncomms11761_CR63","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3233\/JAD-142508","volume":"47","author":"H Liu-Seifert","year":"2015","unstructured":"Liu-Seifert, H. et al. Cognitive impairment precedes and predicts functional impairment in mild Alzheimer\u2019s disease. J. Alzheimers Dis. 47, 205\u2013214 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"BFncomms11761_CR64","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jneumeth.2008.07.020","volume":"175","author":"N Dawson","year":"2008","unstructured":"Dawson, N., Ferrington, L., Olverman, H. J. & Kelly, P. A. Novel analysis for improved validity in semi-quantitative 2-deoxyglucose autoradiographic imaging. J. Neurosci. Methods 175, 25\u201335 (2008).","journal-title":"J. Neurosci. Methods"},{"key":"BFncomms11761_CR65","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1096\/fj.13-229666","volume":"27","author":"S Takeda","year":"2013","unstructured":"Takeda, S. et al. Brain interstitial oligomeric amyloid beta increases with age and is resistant to clearance from brain in a mouse model of Alzheimer\u2019s disease. FASEB J. 27, 3239\u20133248 (2013).","journal-title":"FASEB J."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/ncomms11761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11761","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/ncomms11761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T11:26:26Z","timestamp":1672831586000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/ncomms11761"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,1]]},"references-count":65,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,9,1]]}},"alternative-id":["BFncomms11761"],"URL":"https:\/\/doi.org\/10.1038\/ncomms11761","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,1]]},"assertion":[{"value":"25 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"F.B. is an employee at Johnson & Johnson. The remaining authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11761"}}